Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1Phase 1 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 72Breast Neoplasms 9Neoplasm Metastasis 8Prostatic Neoplasms, Castration-Resistant 6Neoplasms 5Metastatic Castration-resistant Prostate Cancer 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Prostate Cancer Metastatic 3Metastatic Castration Resistant Prostate Cancer 3Bulbo-Spinal Atrophy, X-Linked 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Metastatic Hormone Sensitive Prostate Cancer 2Melanoma 2mCRPC 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Ureteral Diseases 1Solid Tumours 1Small Cell Lung Carcinoma 1Seizures 1Salivary Cancer 1Recurrent Endometrial Endometrioid Adenocarcinoma 1Pancreatic Neoplasms 1Non-metastatic, Hormone naïve Prostate Cancer 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Squamous Cell 1Metastatic Progressive Castration-resistant Prostate Cancer 1

Interventions

enzalutamide 3pembrolizumab 1nilutamide 1bicalutamide 1apalutamide 1Vorinostat 1Tamoxifen 1Panobinostat 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Bulbo-Spinal Atrophy, X-Linked × enzalutamide × Clear all
NCT03437941 2026-05-15

Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Corcept Therapeutics

Phase 1/2 Terminated
39 enrolled 43 charts
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02294461 2025-10-24

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Astellas Pharma Inc

Phase 3 Completed
395 enrolled 25 charts
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT03478904 2021-05-10

Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
1 enrolled 8 charts
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡